newsfilter
← Latest News
GlobeNewswire·

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

FOSTER CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product